Memorial Sloan-Kettering Cancer Center; Hospital for Cancer and Allied Diseases, founded in 1884, is dedicated to improving the understanding and control of cancer through programs in patient care, research, and education. As the world's oldest and largest private institution devoted to this purpose, Memorial has consistently set the standard of care for people with cancer by emphasizing early detection, precise diagnosis, and individually tailored treatment.

Memorial Hospital's Mission is to lead in the prevention, diagnosis, treatment, and cure of cancer and associated diseases through programs of excellence in research, education, outreach, and cost-effective patient care.

Dr. Paul Chapman; The overall goal of Dr. Chapman's research is to develop new and effective treatments to treat metastatic melanoma. His work has focused on three different approaches: chemotherapy, immune therapy, and agents designed to interfere with biochemical pathways critical for melanoma growth.

“I would like to personally thank Dr. Chapman, Dr. Brennan and the staff at Sloan-Kettering for all of their hard work and dedication to this disease. They have given me a new lease on life”-Danny Federici

For more information on Dr. Chapman's research, Dr. Brennan (Danny's surgeon) and Memorial Sloan-Kettering, please visit www.mskcc.org

www.mskcc.org/prg/PRG/bios/92.cfm (for Dr. Paul Chapman's information)

www.mskcc.org/prg/PRG/bios/1.cfm (for Dr. Murray Brennan's information)

Layout/Photography and Design by Jason Federici; federici1000@hotmail.com